Novel preservation solution for alveolar lavage fluid microbial nucleic acid

A technology of alveolar lavage fluid and microorganisms, which is applied in the field of molecular biology, can solve the problems of high difficulty in clinical detection, strict requirements on the delivery time of alveolar lavage fluid and storage conditions, etc., to maintain cell osmotic pressure, avoid cell lysis, The effect of preventing cell lysis

Pending Publication Date: 2020-11-17
广州源古纪科技有限公司
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

If it cannot be sent for inspection in time, it needs to be stored in a refrigerator at 4°C, and the storage time is only about 24 hours. This is also more stringent for the inspection time and storage conditions of alveolar lavage fluid, which brings more difficulties to clinical testing.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel preservation solution for alveolar lavage fluid microbial nucleic acid
  • Novel preservation solution for alveolar lavage fluid microbial nucleic acid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A new preservation solution for microbial nucleic acid in alveolar lavage fluid, treatment solution I and treatment solution II, wherein treatment solution I includes 6M guanidine hydrochloride buffer solution, 8mM nuclease inhibitor, 5mM metabolic inhibitor, 0.3M alkali metal halide, 10 % glycerol, the balance is water; the treatment liquid II includes 4M alkali metal hydroxide and 0.5% surface active, and the balance is water.

[0020] When in use, equal volumes of the treatment solution I and the treatment solution II are mixed to obtain the novel preservation solution of microbial nucleic acid in the alveolar lavage fluid.

Embodiment 2

[0022] A new type of preservation solution for microbial nucleic acid in alveolar lavage fluid, treatment solution I and treatment solution II, wherein treatment solution I includes 8M guanidine hydrochloride buffer solution, 5mM nuclease inhibitor, 3mM metabolic inhibitor, 0.5M alkali metal halide, 5 % glycerol, the balance is water; the treatment solution II includes 3M alkali metal hydroxide and 0.3% surface active, and the balance is water.

[0023] When in use, equal volumes of the treatment solution I and the treatment solution II are mixed to obtain the novel preservation solution of microbial nucleic acid in the alveolar lavage fluid.

Embodiment 3

[0025] A new type of preservation solution for microbial nucleic acid in alveolar lavage fluid, treatment solution I and treatment solution II, wherein treatment solution I includes 5M guanidine hydrochloride buffer solution, 10mM nuclease inhibitor, 2mM metabolic inhibitor, 0.2M alkali metal halide, 10 % glycerol, the balance is water; the treatment liquid II includes 5M alkali metal hydroxide and 1% surface active, and the balance is water.

[0026] When in use, equal volumes of the treatment solution I and the treatment solution II are mixed to obtain the novel preservation solution of microbial nucleic acid in the alveolar lavage fluid.

[0027] When using the above novel preservation solution for microbial nucleic acid to process and preserve the alveolar lavage fluid, the volume ratio of the alveolar lavage fluid sample to the novel preservation solution for microbial nucleic acid is 1:3.

[0028] In order to verify the effectiveness of the novel preservation solution of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel preservation solution for an alveolar lavage fluid microbial nucleic acid. The preservation solution comprises a treatment solution I and a treatment solution II, wherein the treatment solution I comprises a guanidine hydrochloride buffer solution, a nuclease inhibitor, a metabolism inhibitor, an alkali metal halide and glycerol, and the treatment solution II comprises an alkali metal hydroxide and a surfactant. The treatment solution I and the treatment solution II which are separately stored are used as the novel preservation solution for the alveolar lavage fluid microbial nucleic acid, so that the preservation solution can be prevented from generating precipitates, at the same time, different interference impurities can be treated respectively in a targeted manner, alveolar lavage fluid samples can be rapidly stabilized, the activity of nuclease is effectively inhibited, the cell lysis is prevented, at the same time, the free nucleic acid in the alveolar lavage fluid can be well protected, the preservation time is long, the accuracy and convenience of nucleic acid detection are improved, and thereby the preservation solution has great applicationvalue in the detection and diagnosis of tumor diseases, viruses and the like.

Description

technical field [0001] The invention relates to the technical field of molecular biology, and more particularly relates to a novel preservation solution of microbial nucleic acid in alveolar lavage fluid. Background technique [0002] The alveolar lavage fluid is directly inserted into the airway with a fiberoptic bronchoscope to reach the site of inflammation or lesion, inject sterile saline through the fiberoptic bronchoscope, and repeatedly suck the liquid out. The components of alveolar lavage fluid include cells, pulmonary surfactant, inflammatory mediators, growth factors, various proteins, enzymes, lipids, nucleic acids, etc. In clinical practice, alveolar lavage fluid is mainly used for pathogenic microorganism inspection, tumor disease detection and diagnosis, etc. Nucleic acid is the general term for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). With the development of modern molecular biology, the existence of nucleic acid (including RNA and DNA) has b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6806
CPCC12Q1/6806C12Q2527/127C12Q2527/125
Inventor 段志峰
Owner 广州源古纪科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products